Emergent BioSolutions Inc. (0IGA)
LSE
Closed
Sep 28, 2026
Day's Range
6.6452 wk Range
4.37Overview - 0IGA - Emergent BioSolutions Inc.
Key Statistics
Valuation
Enterprise Value
802.28M
P/E (Trailing)
‪0.02‬
Price / Sales (TTM)
‪1.75‬
Price / Book
‪1.03‬
EV / EBITDA
‪3.45‬
Profitability
Gross Margin
‪95.60%‬
Profit Margin
‪-22.95%‬
Operating Margin
‪28.34%‬
Return on Assets
‪6.93%‬
Return on Equity
‪-40.29%‬
Ownership
Shares Outstanding
50.94M
Float
49.06M
Held by Insiders
‪4.25%‬
Held by Institutions
‪90.73%‬
Price stats
Beta
‪2.33‬
50-Day Avg
‪2.24‬
200-Day Avg
‪4.13‬
Market Cap - 0IGA - Emergent BioSolutions Inc.
Peers - 0IGA - Emergent BioSolutions Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
Profile Summary - 0IGA - Emergent BioSolutions Inc.
About
Emergent BioSolutions Inc. is a life sciences company focused on preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats. Its current business centers on medical countermeasures and specialty products, including public health protection tools used by government…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
